Edin Carl, Ekstedt Mattias, Scheffel Tobias, Karlsson Markus, Swahn Eva, Östgren Carl Johan, Engvall Jan, Ebbers Tino, Leinhard Olof Dahlqvist, Lundberg Peter, Carlhäll Carl-Johan
Division of Diagnostics and Specialist Medicine, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Department of Gastroenterology in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Front Cardiovasc Med. 2022 Jul 28;9:813427. doi: 10.3389/fcvm.2022.813427. eCollection 2022.
Different regional depots of fat have distinct metabolic properties and may relate differently to adverse cardiac remodeling. We sought to quantify regional depots of body fat and to investigate their relationship to cardiac structure and function in Type 2 Diabetes (T2D) and controls.
From the SCAPIS cohort in Linköping, Sweden, we recruited 92 subjects (35% female, mean age 59.5 ± 4.6 years): 46 with T2D and 46 matched controls. In addition to the core SCAPIS data collection, participants underwent a comprehensive magnetic resonance imaging examination at 1.5 T for assessment of left ventricular (LV) structure and function (end-diastolic volume, mass, concentricity, ejection fraction), as well as regional body composition (liver proton density fat fraction, visceral adipose tissue, abdominal subcutaneous adipose tissue, thigh muscle fat infiltration, fat tissue-free thigh muscle volume and epicardial adipose tissue).
Compared to the control group, the T2D group had increased: visceral adipose tissue volume index ( < 0.001), liver fat percentage ( < 0.001), thigh muscle fat infiltration percentage ( = 0.02), LV concentricity ( < 0.001) and LV E/e'-ratio ( < 0.001). In a multiple linear regression analysis, a negative association between liver fat percentage and LV mass (St Beta -0.23, < 0.05) as well as LV end-diastolic volume (St Beta -0.27, < 0.05) was found. Epicardial adipose tissue volume and abdominal subcutaneous adipose tissue volume index were the only parameters of fat associated with LV diastolic dysfunction (E/e'-ratio) (St Beta 0.24, < 0.05; St Beta 0.34, < 0.01, respectively). In a multivariate logistic regression analysis, only visceral adipose tissue volume index was significantly associated with T2D, with an odds ratio for T2D of 3.01 (95% CI 1.28-7.05, < 0.05) per L/m increase in visceral adipose tissue volume.
Ectopic fat is predominantly associated with cardiac remodeling, independently of type 2 diabetes. Intriguingly, liver fat appears to be related to LV structure independently of VAT, while epicardial fat is linked to impaired LV diastolic function. Visceral fat is associated with T2D independently of liver fat and abdominal subcutaneous adipose tissue.
不同区域的脂肪储存具有不同的代谢特性,与不良心脏重塑的关系可能也有所不同。我们试图量化身体脂肪的区域储存,并研究它们与2型糖尿病(T2D)患者及对照组心脏结构和功能的关系。
从瑞典林雪平的SCAPIS队列中,我们招募了92名受试者(35%为女性,平均年龄59.5±4.6岁):46名T2D患者和46名匹配的对照组。除了SCAPIS核心数据收集外,参与者还接受了1.5T的全面磁共振成像检查,以评估左心室(LV)结构和功能(舒张末期容积、质量、同心性、射血分数),以及区域身体成分(肝脏质子密度脂肪分数、内脏脂肪组织、腹部皮下脂肪组织、大腿肌肉脂肪浸润、无脂肪组织的大腿肌肉体积和心外膜脂肪组织)。
与对照组相比,T2D组的以下指标升高:内脏脂肪组织容积指数(<0.001)、肝脏脂肪百分比(<0.001)、大腿肌肉脂肪浸润百分比(=0.02)、LV同心性(<0.001)和LV E/e'比值(<0.001)。在多元线性回归分析中,发现肝脏脂肪百分比与LV质量(标准β-0.23,<0.05)以及LV舒张末期容积(标准β-0.27,<0.05)之间呈负相关。心外膜脂肪组织容积和腹部皮下脂肪组织容积指数是与LV舒张功能障碍(E/e'比值)相关的仅有的脂肪参数(标准β分别为0.24,<0.05;标准β为0.34,<0.01)。在多因素logistic回归分析中,只有内脏脂肪组织容积指数与T2D显著相关,内脏脂肪组织容积每增加1L/m,T2D的比值比为3.01(95%CI 1.28-7.05,<0.05)。
异位脂肪主要与心脏重塑相关,独立于2型糖尿病。有趣的是,肝脏脂肪似乎独立于内脏脂肪与LV结构有关,而心外膜脂肪与LV舒张功能受损有关。内脏脂肪独立于肝脏脂肪和腹部皮下脂肪组织与T2D相关。